Use of indolocarbazole derivatives to treat a pathological...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 498/22 (2006.01) A61K 31/395 (2006.01) A61K 31/55 (2006.01) C07D 487/14 (2006.01) C07D 519/00 (2006.01) C07H 19/04 (2006.01)

Patent

CA 2163904

The invention features a method of treating a pathological condi- tion of the prostate gland, e.g., benign prostatic hypertrophy or prostate cancer, in a mammal, said method comprising administering to said mammal a therapeutic amount of the indolocarbazole compound K- 252a or a preferred derivative thereof. The invention also includes novel derivatives of K-252a.

L'invention concerne une méthode de traitement d'une affection dede la prostate telle que l'hypertrophie prostatique bénigne ou le cancer de la prostate. Ladite méthode consiste à administrer en dose thérapeutique audit mammifère ledit composé d'indolocarbazole K.252a ou un dérivé préféré de celui-ci. L'invention porte également sur de nouveaux dérivés de K.252a.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of indolocarbazole derivatives to treat a pathological... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of indolocarbazole derivatives to treat a pathological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of indolocarbazole derivatives to treat a pathological... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1419035

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.